L-arginine Clinical Trials

Size	Price	Qty
25mg	USD 147
1g	USD 970

Clinical Trials

L-arginine is evaluated in numerous clinical trials across various clinical phases and non-interventional protocols, predominantly sponsored by academic institutions and medical centers. These studies encompass completed, active, recruiting, and pending recruitment statuses to investigate diverse therapeutic applications ranging from cardiovascular and respiratory diseases—such as hypertension and asthma—to oncology and dental conditions including glioblastoma multiforme and dentine hypersensitivity.

NCT Number	Recruitment	Conditions	Sponsor/Collaborators	Start Date	Phases
NCT06860724	RECRUITING	Major Depressive Disorder	University of Delaware	2025-01-06
NCT07772882	NOT_YET_RECRUITING	Platinum Resistant Ovarian Cancer; Fallopian Tube Cancers; Peritoneal Carcinoma	Rebecca Arend	2026-09	PHASE1
NCT04800692	ACTIVE_NOT_RECRUITING	Claudication, Intermittent; Peripheral Artery Disease; Peripheral Vascular Diseases	Louis Messina	2021-06-15	PHASE1
NCT07394270	NOT_YET_RECRUITING	Heart Failure	German University in Cairo	2026-02	PHASE2
NCT07150806	RECRUITING	Recurrent Meningioma	Joshua Palmer	2025-11-12	PHASE1; PHASE2
NCT03982160	ACTIVE_NOT_RECRUITING	Chronic Kidney Disease	The University of Texas at Arlington	2018-02-01	PHASE4
NCT06159608	RECRUITING	E-cigarette Use	Anna Stanhewicz, PhD	2023-12-02	EARLY_PHASE1
NCT06379217	ACTIVE_NOT_RECRUITING	Metastatic Neuroendocrine Prostate Cancer	Novartis Pharmaceuticals	2024-07-29	PHASE1
NCT07338682	RECRUITING	Cognition Disorders in Old Age; Cognitive and Behavioral Impairment	German University in Cairo	2025-08-27	PHASE2
NCT06790771	COMPLETED	Hunger	Texas Christian University	2025-01-15
NCT06439875	COMPLETED	Chronic Obstructive Pulmonary Disease; Respiratory Failure	Istituti Clinici Scientifici Maugeri SpA	2024-07-16
NCT07020754	COMPLETED	Radiation Induced Oral Mucositis; Oral Mucositis; Oral Mucositis Due to Radiation	Ain Shams University	2025-04-01	PHASE2
NCT03885245	RECRUITING	Asthma; Obesity	University of Colorado, Denver	2021-10-01	PHASE2
NCT06686069	NOT_YET_RECRUITING	Diabetes; Pre-diabetes; Metabolic Syndrome	Federico II University	2025-01-18
NCT06865261	UNKNOWN	Sarcopenia	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	2024-05-20
NCT06054633	RECRUITING	Osteoarthritis, Knee	Xiangya Hospital of Central South University	2024-03-20
NCT07135037	RECRUITING	Oligohydramnios	Kafrelsheikh University	2024-09-01	PHASE2
NCT03449251	UNKNOWN	Cardiovascular Diseases; Type 2 Diabetes Mellitus	Cambridge University Hospitals NHS Foundation Trust	2018-03-28	PHASE2
NCT06728644	COMPLETED	Polycystic Ovary Syndrome; L-arginine; Gut Microbiome	Shanghai 10th People's Hospital	2024-07-14
NCT07347509	COMPLETED	Ergogenic Support and Performance	Ataturk University	2025-01-10
NCT07548541	COMPLETED	Anaerobic Performance; Cognitive Performance; Healthy Volunteers	Inonu University	2025-04-01
NCT06380465	UNKNOWN	Cerebral Small Vessel Diseases	Indonesia University	2024-04-22
NCT06947265	COMPLETED	Erectile Dysfunctions	Fayoum University Hospital	2024-01-14	PHASE4
NCT06405243	UNKNOWN	Polycystic Ovary Syndrome	Beni-Suef University	2024-06-30	PHASE3
NCT05470998	COMPLETED	Sickle Cell Disease	Tanta University	2022-07-25	PHASE3
NCT06044194	UNKNOWN	Heart Failure	Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico	2023-03-21	PHASE3
NCT06475391	UNKNOWN	Skeletal Muscle; Human Performance	University of Manitoba	2024-06-14
NCT04839354	COMPLETED	Sickle Cell Disease	Claudia R. Morris	2021-06-21	PHASE3
NCT06405477	UNKNOWN	Nutrition, Healthy	Universidade Estadual Paulista Júlio de Mesquita Filho	2024-02-15
NCT06938126	COMPLETED	Healthy	Hungarian University of Sports Science	2023-10-01
NCT06381934	Not yet recruiting	Thiazide Associated Hyponatremia	University Hospital Basel Switzerland	2024-05	Not Applicable
NCT06753526	COMPLETED	Stone Lower Ureter	Sohag University	2023-07-01	PHASE4
NCT06213610	UNKNOWN	Bioequivalence	Pharmtechnology LLC	2024-01-09	PHASE1
NCT06265623	Not yet recruiting	Chronic Obstructive Pulmonary Disease (COPD)	Universitätsklinikum Hamburg-Eppendorf	2024-03-01	--
NCT06273930	Recruiting	Sensitivity Tooth	Armed Forces Institute of Dentistry Pakistan	2024-02-01	Phase 1
NCT05765487	COMPLETED	Sexual Arousal Disorder	Daré Bioscience, Inc.	2023-05-13	PHASE1
NCT05653895	COMPLETED	PCOS	Khyber Medical University Peshawar	2022-12-07
NCT06182267	COMPLETED	Caries,Dental	Colgate Palmolive	2023-11-27	PHASE1
NCT03402191	UNKNOWN	Thalassemia	Sherief Abd-Elsalam	2016-07	PHASE4
NCT05932979	WITHDRAWN	Presbyvestibulopathy	Centro Universitario de Tonalá	2023-05-02	PHASE2
NCT03665116	UNKNOWN	Knee Osteoarthritis	Memorial University of Newfoundland	2019-03-05
NCT05920707	UNKNOWN	Healthy	University of Electronic Science and Technology of China	2023-04-20
NCT03679780	COMPLETED	Cardiovascular Diseases; Cardiovascular Risk Factor; Vasoconstriction	The University of Texas at Arlington	2018-10-01	PHASE1
NCT04474808	COMPLETED	Diabetes Mellitus	West German Center of Diabetes and Health	2020-08-01
NCT05281562	TERMINATED	Diabetes Mellitus; Diabetic Peripheral Neuropathy; Diabetic Foot Ulcer	Prisma Health-Midlands	2023-02-08	PHASE2; PHASE3
NCT04535427	UNKNOWN	Rheumatoid Arthritis	RenJi Hospital	2021-01-01	PHASE2
NCT01791816	COMPLETED	Vasovagal Syncope; Postural Tachycardia Syndrome	New York Medical College	2013-02	EARLY_PHASE1
NCT05656495	COMPLETED	COVID-19	Promomed, LLC	2022-02-28	PHASE3
NCT05448976	COMPLETED	Periodontitis; Smoking; Inflammatory Response	Istanbul Medipol University Hospital	2021-08-12
NCT04631536	UNKNOWN	Covid19	Lebanese American University Medical Center	2021-01-10	PHASE3
NCT04643600	UNKNOWN	Spirometry; Qadriceps Muscle	Goranka Radmilović	2019-03-01	PHASE4
NCT04765644	COMPLETED	Healthy	Imperial College London	2021-06-10	PHASE4
NCT03998800	COMPLETED	Dietary Exposure	Loughborough University	2019-05-01
NCT04054973	WITHDRAWN	Schizo Affective Disorder; Schizophrenia	University of Massachusetts, Worcester	2019-09-11	PHASE2
NCT05029778	UNKNOWN	Fetal Growth Retardation	Hospital Civil de Guadalajara	2021-10-20	PHASE4
NCT02850367	COMPLETED	Physiology	University Hospital, Grenoble	2016-05-09
NCT04626375	COMPLETED	Myocardial Dysfunction	Federico II University	2020-09-14	PHASE4
NCT02838030	SUSPENDED	High Risk Pregnancy	University of Guadalajara	2018-07-01	PHASE2
NCT05470764	COMPLETED	Bioequivalence; Healthy Subjects	Darnitsa Pharmaceutical Company	2021-05-30	PHASE1
NCT05464745	COMPLETED	Bioequivalence; Healthy Subjects	Darnitsa Pharmaceutical Company	2021-05-19	PHASE1
NCT04637906	UNKNOWN	Covid19	University of Campania Luigi Vanvitelli	2020-11-18
NCT02536170	COMPLETED	Sickle Cell Disease; Vaso-occlusive Pain Episode	Emory University	2016-02	PHASE2
NCT03953326	TERMINATED	Breast Cancer; Leukemia; Lymphoma	Penn State University	2019-04-23	PHASE1; PHASE2
NCT04701463	COMPLETED	Amino Acid; Body Weight Changes; Skin Manifestations; Obesity; Postmenopausal Disorder	Azienda di Servizi alla Persona di Pavia	2020-01-15
NCT04239482	TERMINATED	Nitric Oxide; Insulin Sensitivity; Vascular Function; L-arginine; Nitrate / Nitrite	Maastricht University Medical Center	2020-09-01
NCT03625596	COMPLETED	Nitric Oxide; Vascular Function; L-Arginine; Nitrate / Nitrite; Postprandial Metabolism	Maastricht University Medical Center	2018-12-01
NCT04777487	COMPLETED	Periodontal Diseases	Izmir Katip Celebi University	2019-04-01
NCT03861416	COMPLETED	Peripheral Arterial Disease	POLYSAN Scientific & Technological Pharmaceutical Company	2018-03-16	PHASE2
NCT03433963	COMPLETED	Blood Pressure; Cardiac Ischemia	Peking University	2018-01-02
NCT03446612	TERMINATED	Anaemia	GlaxoSmithKline	2019-01-10	PHASE2
NCT02882373	WITHDRAWN	Drug-Induced Nephropathy; Hypertension; Proteinuria	M.D. Anderson Cancer Center	2018-10-23	PHASE2
NCT04254042	COMPLETED	Hypertension	Yaounde Central Hospital	2018-10-01	PHASE4
NCT04112875	COMPLETED	Aging; Sarcopenia; Type 2 Diabetes; Microcirculation	Rio de Janeiro State University	2016-04
NCT05288400	COMPLETED	Essential Hypertension	Servier	2018-05-14	PHASE3
NCT04475861	WITHDRAWN	Diabetes Mellitus, Type 2; Infection	Chang Gung Memorial Hospital	2018-10-31
NCT03321292	UNKNOWN	Intrauterine Growth Restriction Asymmetrical	Ain Shams University	2017-10-15
NCT05042024	COMPLETED	Periodontitis	Ukrainian Medical Stomatological Academy	2017-10-20	PHASE3
NCT03834610	COMPLETED	Erectile Dysfunction	Aswan University Hospital	2017-10-01
NCT01841281	COMPLETED	Asthma; Inflammation	Nicholas Kenyon	2013-08	PHASE2
NCT01855334	WITHDRAWN	End Stage Renal Disease; Hemodialysis	Brigham and Women's Hospital	2013-09	PHASE4
NCT03680573	COMPLETED	Cardiovascular Diseases; Cardiovascular Risk Factor; Vasoconstriction	The University of Texas at Arlington	2018-01-08	PHASE1
NCT03068533	UNKNOWN	Dentin Hypersensitivity	Cairo University	2018-01-01
NCT04222686	COMPLETED	Type 2 Diabetes Mellitus	Yaounde Central Hospital	2017-12-20	PHASE4
NCT03378596	UNKNOWN	Hypertension	Juliano Casonatto	2018-01-02
NCT01439555	COMPLETED	Alzheimer's Disease	University of Massachusetts, Worcester	2011-11	PHASE2
NCT03827005	COMPLETED	Healthy Adult	North Dakota State University	2016-07-16
NCT02869204	UNKNOWN	Wound Infection and Wound Healing	Jens Rikardt Andersen	2016-09
NCT02894723	UNKNOWN	Hypertension	Meir Medical Center	2016-09	PHASE4
NCT00223717	COMPLETED	Hypertension	Vanderbilt University	2001-01	PHASE1
NCT02350478	COMPLETED	Type 2 Diabetes; Coronary Artery Disease	Medical University of Graz	2013-07	PHASE4
NCT01860911	COMPLETED	Obesity; Insulin Resistance	Mayo Clinic	2013-04	PHASE1
NCT02455960	UNKNOWN	Contrast Induced AKI	Phramongkutklao College of Medicine and Hospital	2014-09	PHASE4
NCT01689090	COMPLETED	Diabetes Mellitus Type 1; Diabetic Maculopathy	University of Aarhus	2012-11
NCT02687152	COMPLETED	Type 2 Diabetes Mellitus	Karolinska Institutet	2014-03	PHASE1; PHASE2
NCT01326416	COMPLETED	Obesity; Metabolic Syndrome	University Hospital, Rouen	2011-03
NCT02291458	UNKNOWN	Adipose Tissue, Brown; Glucose Intolerance; Nitric Oxide	Maastricht University Medical Center	2014-11	PHASE3
NCT02017249	COMPLETED	Glioblastoma Multiforme	Inova Health Care Services	2014-03	PHASE1
NCT01485757	TERMINATED	Heart Transplant	University of Michigan	2011-07	PHASE1
NCT04212819	COMPLETED	Anemia; Oxidative Stress	Afyonkarahisar Health Sciences University	2014-01-01
NCT01118520	COMPLETED	Abdominal Aortic Aneurysm	Imperial College London	2011-09	PHASE2
NCT00406731	WITHDRAWN	Ocular Physiology; Optic Disk; Regional Blood Flow	Medical University of Vienna	2008-01	PHASE2
NCT02245165	COMPLETED	Gastrointestinal Motility Disorder; Disturbance of Salivary Secretion	Uppsala University	2013-06	PHASE1
NCT02354794	COMPLETED	Overweight; Hypertriglyceridemic Waist	Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement	2014-02
NCT01617551	UNKNOWN	Essential Hypertension	Regional Hospital Holstebro	2012-03
NCT01105130	COMPLETED	Male Erectile Disorder; Prostate Cancer; Radiation Toxicity	Wake Forest University Health Sciences	2010-10-01	PHASE2
NCT01263041	COMPLETED	NEC; Sepsis	Ain Shams University	2011-05	PHASE2; PHASE3
NCT01482247	COMPLETED	Hypertension; Diabetes	Brigham and Women's Hospital	2012-04	PHASE2
NCT02363348	COMPLETED	Preeclampsia	Hospital Civil Juan I. Menchaca	2010-08	PHASE3
NCT00743210	COMPLETED	Blood Pressure	University of Pittsburgh	2010-01	PHASE1
NCT01603446	COMPLETED	MELAS Syndrome	The Hospital for Sick Children	2012-05	PHASE2
NCT02352740	COMPLETED	Overweight; Hypertriglyceridemic Waist	Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement	2013-03
NCT01556997	COMPLETED	Essential Hypertension	Symplmed Pharmaceuticals LLC	2012-02	PHASE3
NCT00166166	TERMINATED	Hyperlipidemia	Emory University	2002-07	PHASE2
NCT02398279	COMPLETED	Schizophrenia; Schizoaffective Disorder	Hacettepe University	2011-06
NCT02516085	COMPLETED	Duchenne Muscular Dystrophy	University Hospital, Basel, Switzerland	2012-01	PHASE1
NCT01324115	TERMINATED	Unspecified Adult Solid Tumor, Protocol Specific	Cancer Research UK	2011-04	PHASE1
NCT01413815	COMPLETED	Cardiovascular Complication	Universitätsklinikum Hamburg-Eppendorf	2010-10
NCT01388764	COMPLETED	Dystrophinopathy; Duchenne Muscular Dystrophy; Becker's Muscular Dystrophy	Massachusetts General Hospital	2012-01	PHASE1
NCT01290198	COMPLETED	Healthy Volunteers	University Hospital, Grenoble	2011-02
NCT02117206	COMPLETED	Skeletal Muscle Ischemia; Severe Lower Limb Ischemia; Mitochondrial Dysfunction	University Hospital, Strasbourg, France	2005-11	PHASE4
NCT01185041	COMPLETED	Hypertension	Florida State University	2010-08	PHASE1; PHASE2
NCT00914394	TERMINATED	Healthy	Medical University of Vienna	2010-10
NCT00587418	COMPLETED	Liver Transplant Recipients	Mayo Clinic	2008-11
NCT00718510	COMPLETED	Schizophrenia	University of Alberta	2009-09
NCT00848302	COMPLETED	Endothelial Dysfunction	The Cleveland Clinic	2009-09	EARLY_PHASE1
NCT01038622	COMPLETED	Critically Ill	Assistance Publique - Hôpitaux de Paris	2009-11	PHASE4
NCT00753948	COMPLETED	Tetraplegia; Asthma	VA Office of Research and Development	2006-12	PHASE2; PHASE3
NCT01070940	COMPLETED	Healthy	Regional Hospital Holstebro	2010-02	PHASE1
NCT00237770	COMPLETED	Hypotension; Spinal Cord Injury	US Department of Veterans Affairs	2003-06	PHASE2; PHASE3
NCT00806741	COMPLETED	Healthy	Medical University of Vienna	2009-09
NCT00677339	COMPLETED	Smear Positive Pulmonary Tuberculosis	Menzies School of Health Research	2008-06	PHASE3
NCT00759707	COMPLETED	Peripheral Arterial Disease	Brigham and Women's Hospital	2006-04
NCT00554866	COMPLETED	Infant, Very Low Birth Weight	Maastricht University Medical Center	2007-07
NCT00708357	TERMINATED	Ocular Physiology; Regional Blood Flow	Medical University of Vienna	2005-05	EARLY_PHASE1
NCT00137124	COMPLETED	Essential Hypertension	University of Erlangen-Nürnberg Medical School	2006-05	PHASE2; PHASE3
NCT00917449	COMPLETED	Metabolic Syndrome; Impaired Glucose Tolerance; Insulin Resistance; Endothelial Dysfunction	IRCCS San Raffaele	2005-12	PHASE3
NCT00974714	COMPLETED	Hypertension in Pregnancy	University of Modena and Reggio Emilia	2007-09	PHASE3
NCT00405665	COMPLETED	Cystic Fibrosis	The Hospital for Sick Children	2006-11	PHASE2
NCT00616304	SUSPENDED	Severe Falciparum Malaria	Menzies School of Health Research	2008-02	PHASE2
NCT00571766	COMPLETED	Hypertension in Pregnancy	University of Modena and Reggio Emilia	2007-11	PHASE3
NCT00785811	TERMINATED	Muscular Fatigue	Sanofi	2008-10	PHASE4
NCT00280683	COMPLETED	Asthma	University of California, Davis	2004-12	PHASE2
NCT00603720	COMPLETED	Cardiovascular Diseases	Washington University School of Medicine	2005-09
NCT04406402	COMPLETED	Diabetes Mellitus, Type 2; Obesity; Arginine; Asymmetric Dimethylarginine	Tel-Aviv Sourasky Medical Center	2006-12-05
NCT00264706	TERMINATED	Saphenous Vein Graft Disease	Lumen Therapeutics	2005-03	PHASE1; PHASE2
NCT01142219	COMPLETED	Sickle Cell Disease	Hospital de Clinicas de Porto Alegre	2006-09	PHASE3
NCT02844387	COMPLETED	Unresectable Multiple Brain Metastases	Instituto de Oncología Ángel H. Roffo	2004-05	PHASE1; PHASE2
NCT00134433	COMPLETED	Coronary Artery Disease	Ottawa Heart Institute Research Corporation	2004-11	PHASE1; PHASE2
NCT00056433	COMPLETED	Sickle Cell Anemia	National Institutes of Health Clinical Center (CC)	2003-03-10	PHASE1
NCT00180635	COMPLETED	Chronic Obstructive Pulmonary Disease	Imperial College London	2003-10
NCT00284076	COMPLETED	Cardiovascular Diseases; Peripheral Vascular Diseases	Stanford University	2000-02
NCT00902616	COMPLETED	Type 2 Diabetes	Tameside Hospital NHS Foundation Trust	2003-06	PHASE4
NCT00159380	COMPLETED	Asthma	Imperial College London	2003-09
NCT01775020	COMPLETED	Sepsis; Septic Shock	Maastricht University Medical Center	2003-10	EARLY_PHASE1
NCT00345137	COMPLETED	ADPKD; Glomerulonephritis	Regional Hospital Holstebro		PHASE1
NCT00344734	COMPLETED	Congestive Heart Failure	Regional Hospital Holstebro		PHASE1
NCT00431665	COMPLETED	Renal Circulation; Renal Plasma Flow; Glomerular Filtration Rate; Fatty Acids, Nonesterified	Medical University of Vienna	1999-07
NCT00469846	TERMINATED	Pre-Eclampsia	Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes	2001-01	PHASE2
NCT00408577	COMPLETED	Cardiovascular Disease	IRCCS San Raffaele	2004-11	PHASE3
NCT00001752	COMPLETED	Hypercholesterolemia; Postmenopause	National Heart, Lung, and Blood Institute (NHLBI)	1998-09	PHASE2
NCT00344916	COMPLETED	Liver Cirrhosis	Regional Hospital Holstebro		PHASE1
NCT00551434	COMPLETED	Coronary Artery Disease	Boston University	2002-08
NCT00856817	TERMINATED	Atherosclerotic Cardiovascular Disease	Radboud University Medical Center	2009-03	PHASE4
NCT00431392	COMPLETED	Regional Blood Flow; Ocular Physiology	Medical University of Vienna	2001-09	PHASE2
NCT00051376	COMPLETED	Myocardial Infarction	National Heart, Lung, and Blood Institute (NHLBI)	2001-09
NCT00345150	COMPLETED	Hypertension	Regional Hospital Holstebro		PHASE1
NCT00157521	COMPLETED	Pre-Eclampsia	Mario Negri Institute for Pharmacological Research	2002-09	PHASE3
NCT00777075	COMPLETED	Erectile Dysfunction	Hannover Medical School	2003-07	PHASE4
NCT00213915	COMPLETED	Heart Transplantation	University Hospital, Strasbourg, France	2004-02	PHASE4
NCT00410085	COMPLETED	Obstructive Sleep Apnea; Healthy	Regional Hospital Holstebro	2005-01	PHASE4
NCT00549575	TERMINATED	Intra Uterine Growth Retardation	Nantes University Hospital	2000-07	PHASE3
NCT00005107	UNKNOWN	Cirrhosis; Liver Cirrhosis	National Center for Research Resources (NCRR)		PHASE1
NCT00275158	COMPLETED	Pre-Eclampsia	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	2000-01

(data from https://clinicaltrials.gov, updated on 2025-09-17)

Check the L-arginine product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.

Compliance for Clinical Use

Mechanism and Biochemical Profile

As a critical substrate for nitric oxide synthases, L-arginine undergoes enzymatic conversion to synthesize nitric oxide, which stimulates soluble guanylyl cyclase to elevate intracellular cyclic guanosine monophosphate levels and induce vascular smooth muscle relaxation alongside immunomodulation. This activation of the nitric oxide signaling cascade and regulation of cellular immune responses underpin its therapeutic investigation in clinical trials evaluating cardiovascular conditions such as hypertension and cardiac ischemia, as well as respiratory disorders like asthma and glioblastoma multiforme.

Appendix RUO and cGMP Quality Standards

Quality Dimension	RUO (Research Use Only)	cGMP (Current Good Manufacturing Practice)
Clinical Applicability	Prohibited in human clinical trials or medical diagnostics.	Mandatory for human clinical trials (Phase I–III) and therapies.
Regulatory Status	Non-regulated grade; exempt from drug manufacturing laws.	Legally enforced by health authorities (e.g., FDA, EMA, NMPA).
Facility Environment	Unclassified analytical or research laboratories.	Validated Cleanrooms (ISO Class 5–8) with continuous monitoring.
Quality Control	Basic purity and activity testing.	Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma).
Process Validation	Basic equipment calibration; no process validation required.	Full qualification (IQ/OQ/PQ) and complete batch records.
Quality Assurance	Vendor self-declared without required formal QMS.	Mandatory QA/QC unit, Change Control, CAPA, and vendor audits.
Regulatory Impact	High risk of IND rejection if used as a critical raw material.	Required for IND/NDA filings, supported by Drug Master Files (DMF).

Footnotes

Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).